Blood clotting is essential when a person is injured. Without it, even a small wound could cause excessive bleeding. However, a clot that forms inappropriately inside a blood vessel can obstruct circulation and cause serious problems.
A clot in a deep vein may lead to deep vein thrombosis. If part of that clot travels to the lungs, it can cause a pulmonary embolism. These conditions can be life-threatening.
What research has found
Several studies and reviews have reported that non-O blood groups are associated with a higher risk of venous thromboembolism than type O. Some research has also found associations between ABO groups and certain arterial cardiovascular outcomes, although the strength and consistency of these relationships vary.
This is an important distinction: evidence linking blood groups with some clotting-related conditions is stronger than evidence that blood group determines overall longevity.
Even where a relative difference in risk has been measured, the absolute risk for an individual depends on many other factors. Age, previous blood clots, surgery, prolonged immobility, pregnancy, cancer, certain medications, smoking, and inherited clotting disorders can all influence risk.
A person with type O blood is not immune to blood clots. A person with type A, B, or AB blood is not destined to develop one.
Why cardiovascular disease is more complicated
Cardiovascular disease includes several conditions, such as coronary artery disease, heart attack, stroke, peripheral artery disease, and heart failure. These conditions have different causes and mechanisms.
Some are closely related to atherosclerosis, in which fatty deposits build up inside artery walls. Others involve abnormal clot formation, changes in heart function, blood vessel damage, or a combination of processes.
ABO blood type may be relevant to some of these mechanisms, but it is only one factor among many. Blood pressure, cholesterol, diabetes, tobacco exposure, physical activity, diet, and age are often much more actionable parts of cardiovascular risk assessment.
Researchers have reported associations between non-O blood groups and certain cardiovascular outcomes, but results have not been equally consistent across all conditions or study designs. A statistical association in a group of participants should not be treated as a personal prediction.
Does type O mean a longer life?
Not necessarily. If a blood group is associated with a lower risk of one particular condition, that does not establish that people with that group live longer overall.
Lifespan is affected by many causes of illness and death. A possible advantage in one area may be small, may be offset by other risks, or may not translate into a measurable difference in life expectancy.
It is also important not to turn a population-level association into a recommendation for individual medical care. Doctors do not generally advise people to change their lifestyle or treatment solely because they have type O blood. Instead, they assess the person's overall health and established risk factors.
The practical takeaway: Blood type O has been associated with lower average levels of some clotting-related proteins and a lower risk of certain clotting conditions. That does not prove that people with type O blood are more likely to reach 100.
Chapter 5: Blood Type A and the Questions Researchers Are Investigating
Blood type A has also received attention in studies of cardiovascular health. Some research has reported a modest association between type A and certain cardiovascular outcomes compared with type O. Other studies have investigated relationships between ABO blood groups and metabolic or inflammatory conditions.
These findings do not mean that people with type A blood should expect to develop heart disease. They also do not mean that type A shortens life expectancy.
Understanding relative risk
When researchers compare disease rates between groups, they may report a relative risk or odds ratio. These measures describe how an outcome differs between groups under the conditions of a particular study.
A relative increase does not directly tell a person their individual probability of developing a disease. Absolute risk depends on the starting risk and the population being studied.
For example, a modest relative difference may translate into a small absolute difference for a person whose baseline risk is low. The same relative difference can have a different practical meaning in a population with a higher baseline risk.
This is one reason headlines about blood type can be misleading. A study may identify a statistically significant association, but a headline may present it as though a person's future health has been determined.
Possible biological pathways
The ABO system affects more than the labels used for red blood cells. ABO-related molecules are present in other tissues and can influence the behavior of certain proteins involved in clotting and vascular biology.
Researchers are interested in how these differences might contribute to the risk of particular diseases. They also investigate whether blood groups are related to the way the body interacts with some infections or other biological processes.
However, identifying a plausible pathway is only one step toward understanding a disease. Scientists must determine how important that pathway is in real people, whether the association is consistent across populations, and whether it meaningfully changes clinical outcomes.
What should people with type A blood do?
The same health advice applies to people with type A as to those with other blood groups: monitor established health indicators, maintain healthy habits, and seek medical care when appropriate.
People concerned about cardiovascular disease can discuss blood pressure, cholesterol, blood sugar, smoking, family history, and other relevant factors with a healthcare professional.
Blood type alone is not a reason to assume that a person is at high risk, undergo unnecessary testing, or take medication without a medical indication.
The most useful approach is to focus on risks that can be measured and managed. A person's blood group may be biologically interesting, but it does not replace a proper evaluation of their health.
Chapter 6: What About Blood Types B and AB?
Blood types B and AB are also included in research examining the relationship between ABO groups and disease. As with types A and O, the findings depend on the condition being studied and the characteristics of the population.
It would be misleading to describe type B or AB as universally protective or universally harmful.
Blood type B
Type B blood has been investigated in studies of cardiovascular disease, infection, and other health outcomes. Some studies report associations with particular conditions, while others produce different or inconclusive findings.
A person's risk of disease cannot be determined from type B alone. Age, family history, lifestyle, underlying health conditions, and environmental exposures remain important.
Blood type AB
Type AB is less common than several other ABO groups in many populations. This can make research more challenging because studies may have fewer participants with type AB, particularly when researchers further divide participants by age, sex, or specific medical outcomes.
Smaller groups can produce less precise estimates. Apparent differences may be influenced by random variation, and findings need to be replicated before strong conclusions can be drawn.
Some research has explored possible relationships between type AB and cardiovascular or other medical conditions. These findings do not establish that type AB predicts either exceptional longevity or a shorter life.
Why one disease cannot stand in for overall health
Suppose a study finds that one blood group is associated with a slightly lower risk of a particular disease. That result cannot automatically be generalized to cancer, infections, dementia, or every other cause of illness.